Homeostatic maintenance of T cells and natural killer cells by Boyman, Onur et al.
MULTI-AUTHOR REVIEW
Homeostatic maintenance of T cells and natural killer cells
Onur Boyman • Carsten Krieg • Dirk Homann •
Jonathan Sprent
Received: 10 March 2012 / Revised: 13 March 2012 / Accepted: 13 March 2012 / Published online: 30 March 2012
 Springer Basel AG 2012
Abstract Homeostasis in the immune system encom-
passes the mechanisms governing maintenance of a
functional and diverse pool of lymphocytes, thus guaran-
teeing immunity to pathogens while remaining self-
tolerant. Antigen-naı¨ve T cells rely on survival signals
through contact with self-peptide-loaded major histocom-
patibility complex (MHC) molecules plus interleukin (IL)-7.
Conversely, antigen-experienced (memory) T cells are
typically MHC-independent and they survive and undergo
periodic homeostatic proliferation through contact with
both IL-7 and IL-15. Also, non-conventional cd T cells rely
on a mix of IL-7 and IL-15 for their homeostasis, whereas
natural killer cells are mainly dependent on contact with
IL-15. Homeostasis of CD4? T regulatory cells is different
in being chiefly regulated by contact with IL-2. Notably,
increased levels of these cytokines cause expansion of
responsive lymphocytes, such as found in lymphopenic
hosts or following cytokine injection, whereas reduced
cytokine levels cause a decline in cell numbers.
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TGF-b Transforming growth factor-b
TLR Toll-like receptor
Treg T regulatory cell
TSLP Thymic stromal lymphopoietin
cc Common c chain
Introduction
Throughout their lives, lymphocytes are probed for their
capacity to mount efficient responses upon contact with
antigen, while maintaining self-tolerance. For ab T cell
receptor (TCR)? T cells, this process starts at their pre-
cursor stage during thymic selection and continues in the
periphery in antigen-naı¨ve and antigen-experienced
(memory) T cells. Extrinsic factors, most notably common
c chain (cc) cytokines and basal TCR signals, control and
maintain a stable pool size of ab TCR? T cells from the
newborn stage up to old age. Such homeostasis also applies
to other lymphocyte subsets, including cd TCR? T cells
and natural killer (NK) cells. Below, we will provide a
brief overview on the generation and activation of typical
ab TCR? T cells (hereafter referred to as T cells), followed
by a systematic review of the factors governing homeo-
static survival, proliferation, and expansion of T cells and
other lymphocyte subsets.
T cells are scrutinized at a precursor stage in the thymus
for their capacity to receive TCR-mediated survival signals
(a process termed positive selection) through contact with
self-peptide-loaded major histocompatibility complex
(MHC) molecules on epithelial cells in the thymic cortex;
these stromal cells also produce the pro-survival cytokine
interleukin (IL)-7. Subsequently, negative selection deletes
T cells with high affinity for self-peptide/MHC molecules
on professional antigen-presenting cells (APCs) and epi-
thelial cells in the medulla [1]. Upon completion of these
steps, mature CD4? and CD8? thymocytes are released
into the periphery and join the pool of naı¨ve T cells. At this
stage, naı¨ve T cells rarely, if ever, undergo cell division but
continuously screen the surface of APCs in secondary
lymphoid organs for their cognate antigen. Upon encounter
with antigen on activated APCs, naı¨ve T cells become fully
stimulated and undergo massive proliferation and expan-
sion, thereby giving rise to effector T cells that are able to
kill target cells and release effector cytokines [2]. The
majority of effector T cells are characterized by high
expression of killer cell lectin-like receptor G1 (KLRG1),
and most of these cells are eliminated via apoptosis upon
clearance of the pathogen concerned, leaving a few anti-
gen-specific T cells characterized by high IL-7 receptor a
(CD127) surface expression to survive as memory T cells
[3]. Compared to their naı¨ve counterparts, memory T cells
have the ability to mount more rapid and enhanced immune
responses upon renewed contact with the same pathogen or
antigenic determinant [2].
Typical memory T cells are long-lived and migrate
between the secondary lymphoid organs via lymph and
blood. These so-called ‘‘central’’ memory T cells express
specific homing molecules, namely chemokine receptor
CCR7 and CD62L (L-selectin), which enable their migra-
tion to the T cell zones of lymph nodes (LNs) [4].
Conversely, expression of these homing molecules is very
low on another memory T cell subset found mainly in
peripheral tissues and blood, termed ‘‘effector’’ memory T
cells [4–6]. Both subsets are characterized by high surface
expression of the adhesion molecule CD44 (CD44high),
whereas naı¨ve T cells have a CD44low phenotype. It should
be noted that small numbers of polyclonal T cells with a
memory-phenotype (MP) are found in unimmunized ani-
mals; many of these MP cells are thought to arise through
contact with self-antigens [7]. Unless stated otherwise, the
discussion of memory and MP T cells below refers to
central rather than effector memory cells.
T cells
T cell receptor signals
Once T cells have exited the thymus, they are dependent on
the same pattern of survival signals they received during
their development in the thymus. In particular, survival of
antigen-naı¨ve T cells requires continued contact with self-
peptide/MHC molecules, MHC class II for CD4? T cells,
and MHC class I for CD8? T cells [8–12]. Notably, the
survival signals delivered via TCR contact with self-pep-
tide/MHC molecules are peptide specific, and there is
considerable competition among naı¨ve T cells of a given
antigen specificity for contact with appropriate self-pep-
tide/MHC molecules [13]. Significantly, this TCR-self-
peptide/MHC interaction does not induce naı¨ve T cells to
proliferate and attack self, but rather, in synergy with IL-7,
provides low-level signals that maintain cell survival in
interphase [14, 15]. Contact with these survival factors
occurs in secondary lymphoid organs, such as LNs, where
professional APCs and local stromal cells provide a rich
source of MHC molecules and IL-7, respectively [15–18].
In line with this model, numbers of naı¨ve T cells are sig-
nificantly reduced under conditions where homing to LNs
is hampered because of decreased levels of CD62L or
CCR7. Thus, antibody-mediated blocking of CD62L or
deficiency of the transcription factors Kruppel-like factor 2
(KLF2) or forkhead box o1 (Foxo1) leads to reduced levels
of CD62L, CCR7, and sphingosine 1 phosphate receptor 1
(S1P1), and is associated with a severe reduction in naı¨ve T
cell numbers [19–21].
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In contrast to naı¨ve T cells, memory T cell homeostasis
does not require TCR contact with MHC molecules
[22–25]. However, under certain circumstances, memory
T cells remain dependent on peptide/MHC molecules, for
example during chronic infections and autoreactive
responses against self-antigens [15, 26]. The observations
from acute and chronic viral infection models emphasize
that memory CD8? T cells of identical pathogen specificity
rely, depending on the pathophysiological context, on
distinct mechanisms to assure their maintenance. Thus,
memory CD8? T cells generated following acute infections
depend on a mix of particular cytokines (see below) for
their survival and homeostatic proliferation, whereas
memory CD8? T cells forming during chronic infections
require contact with cognate antigen/MHC molecules [15,
25, 26].
For CD4? T regulatory cells (Tregs), whether homeo-
stasis of these cells requires contact with self-peptide/MHC
molecules is controversial. In one study, mice expressing
MHC class II molecules selectively on thymic cortical
epithelial cells, but not in peripheral tissues, contained a
comparably normal pool size of Tregs, suggesting that
post-thymic Tregs do not require contact with self-peptide/
MHC molecules [27]. Conversely, a more recent study
using mice with abrogated TCR signaling capacity showed
decreased homeostatic proliferation of Tregs in vivo [28].
Cytokines sharing the common c chain receptor
The cc receptor (CD132) is a subunit of the cytokine
receptors for IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21, all of
which play crucial roles during lymphocyte generation,
survival, and homeostasis. For all cc cytokines, selectivity
for individual cytokines is determined by their private
a chain [29]. Moreover, for IL-2 and IL-15, a shared
b subunit for the IL-2 and IL-15 receptor (CD122) is
involved in cytokine binding and signaling. Cytokine
binding and signaling through cc leads to the activation of
different signal transduction molecules, including signal
transducer and activator of transcription (STAT) 5A and
5B, Janus kinase (Jak) 1 and 3, and, in the case of pro-
survival signals to T cells, favorably shifts the balance
between anti-apoptotic (e.g., Bcl-2) and pro-apoptotic (e.g.,
Bim) molecules towards the former [29, 30]. Synthesis of
cc cytokines can occur in both immune and non-immune
cells. Thus, IL-2 is produced mainly by activated T cells,
predominantly CD4? T cells, in secondary lymphoid
organs and, to a lesser extent, also by NK cells, NK T cells,
and activated dendritic cells [31]. For IL-7, stromal cells in
primary and secondary lymphoid organs secrete high
amounts of IL-7 at a constant rate, followed by its pre-
sentation on extracellular matrix in these lymphoid as well
as non-lymphoid organs (e.g., skin, intestine, and liver)
[17, 32–34] (Fig. 1). Also, hepatocytes can produce rele-
vant amounts of IL-7, for example upon treatment of mice
with lipopolysaccharide (LPS) [33]. IL-15 is synthesized in
APCs upon triggering with Toll-like receptor (TLR) ago-
nists, such as poly(I:C) and LPS, leading to autocrine
stimulation of APCs via type I interferon (IFN-I) [35].
Alternatively, IL-15 can be produced following activation
of APCs with type II IFN, such as IFN-c derived either
from NK cells stimulated with IL-12 and IL-18, activated
Fig. 1 Regulation of the IL-7 receptor a chain CD127. IL-7 (light
purple dots) is usually produced at a constant rate by stromal cells
residing in the primary and secondary lymphoid organs. Subse-
quently, IL-7 accumulates on extracellular matrix and is presented to
lymphocytes, here a T cell, expressing the IL-7 receptor, composed of
the cc (light brown bar) and the IL-7 receptor a chain CD127 (purple
bar). Both these IL-7 receptor subunits contain cytoplasmic tails
interacting with signaling molecules, such as Jak 1 and 3. Signals
emerging from Jak 1 and 3 lead, via activation of STAT5A and 5B, to
the upregulation of anti-apoptotic proteins such as Bcl-2 and
downregulation of pro-apoptotic proteins such as Bim in mitochon-
dria (light blue oval), thus tipping the balance in favor of pro-survival
signals. Transcription of the Cd127 gene and thus upregulation of
CD127 is positively influenced by contact with cc cytokines, GABPa,
and Foxo1. Foxo1 enhances expression of KLF2 thus leading to
upregulation of the chemokine receptor CCR7, CD62L (L-selectin),
and S1P1. Conversely, under certain conditions, contact with pro-
survival cc cytokines may induce activation of Gfi-1 in vitro, which
either directly or via inhibition of GABPa may downregulate CD127.
Moreover, strong TCR stimulation (and proliferation) may also lead
to decreased CD127 expression, either directly or via activation of
Gfi-1. Foxo1 forkhead box o1, Gfi-1 growth factor independence 1,
Jak Janus kinase, KLF2 Kruppel-like factor 2, STAT5 signal
transducer and activator of transcription 5, TCR T cell receptor,
S1P1 sphingosine 1 phosphate receptor 1, cc common c chain
T and NK cell homeostasis 1599
123
NK T cells, or effector T cells [36]. Subsequently, APCs
synthesize IL-15 and transport it to their surface in asso-
ciation with IL-15Ra, where it is presented in trans to
IL-15-sensitive T and NK cells [37] (Fig. 2). As discussed
in detail in the following sections, IL-7 and IL-15 are
crucial for homeostatic survival and proliferation of
conventional T cells, whereas IL-2 signals are essential for
the homeostasis of Tregs [38, 39].
The major role of IL-2 in vivo appears to be in mediating
development and homeostasis of Tregs, thus maintaining
peripheral immune tolerance [39]. CD4? Tregs typically
express high levels of IL-2Ra (CD25) and the transcription
factor Foxp3, the latter being essential for Treg function
[40]. Optimal expression of Foxp3 and CD25 is dependent
on contact with IL-2 [40]. Moreover, in conjunction with
transforming growth factor (TGF)-b, IL-2 signals are also
crucial during Treg development in the thymus, as well as
for homeostatic proliferation and survival of Tregs in
peripheral LNs [39–43]. Thus, IL-2-/-, CD25-/-, and
CD122-/- mice, which all lack normal IL-2 signaling, show
a considerable reduction in Treg numbers, thereby leading to
systemic autoimmune disease in these mice [39–41]. Con-
versely, Treg numbers increase several-fold in lymphoid and
non-lymphoid organs of mice receiving injections of IL-2 in
the form of recombinant IL-2 mixed with a particular anti-
IL-2 monoclonal antibody (mAb); such IL-2/anti-IL-2 mAb
complexes focus IL-2 onto CD25? cells and expand these
cells [44, 45]. It should be noted that, although Tregs con-
sume IL-2 and express a high level of CD25 under steady-
state conditions, these cells do not produce IL-2 [39]. Thus,
it has been suggested that Tregs might exert some of their
suppressive function by consumption of IL-2 (and other pro-
survival cc cytokines) via their high surface density of CD25
[31, 46]. Notably, certain other immune cells as well as some
non-immune cells express CD25, albeit at much lower lev-
els, and blocking CD25 on these cells with antibody or the
use of CD25-/- mice also leads to high levels of IL-2,
thereby causing strong IL-2-mediated proliferation of MP
CD8? T cells [31, 47, 48]. In contrast to IL-2, administration
of IL-4 to normal mice led to a reduction of CD4? Foxp3?
Tregs [49].
With regard to conventional T cells, several recent
studies have revisited the role of IL-2 during priming of
naı¨ve T cells and shown that provision of IL-2 is important
for inducing optimal T cell responses [48]. Thus, IL-2
signals during priming of naı¨ve CD4? and CD8? T cells
optimize expansion of these cells and allow them to survive
as long-lived memory cells, in part due to IL-2-induced
high expression of CD127 on the cells [50, 51]. Moreover,
for CD8? T cells, it has been shown that contact with IL-2
during primary infection with the lymphocytic chorio-
meningitis virus (LCMV) allows antigen-specific memory
CD8? T cells to efficiently respond to secondary challenge
with the same virus [52, 53]. However, in addition to the
qualitative effects of receiving IL-2 signals during priming,
contact with IL-2 can have a quantitative effect on CD25
expression on effector T cells. Thus, effector T cells
showing prolonged expression of high CD25 generally
become short-lived effector cells, whereas the fraction of
Fig. 2 Regulation of the IL-15 receptor b chain CD122. IL-15 (light
green dots) is produced by APCs along with its a chain IL-15Ra.
Upon intracellular association of IL-15 with IL-15Ra, both are
transported onto the surface of the APC and presented in trans to
lymphocytes, here a CD8? T cell, expressing the dimeric IL-15
receptor, composed of the cc (light brown bar) and the IL-15 receptor
b chain CD122 (light green bar). (Notably, IL-15-responsive
lymphocytes may also express IL-15Ra on their own surface, which
is not shown here.) Both these IL-15 receptor subunits contain
cytoplasmic tails interacting with signaling molecules, such as Jak 1
and 3. Signals emerging from Jak 1 and 3 lead, via activation of
STAT5A and 5B, to the upregulation of anti-apoptotic proteins such
as Bcl-2 and downregulation of pro-apoptotic proteins such as Bim in
mitochondria (light blue oval), thus favoring pro-survival signals.
SOCS1 is able to directly inhibit the activity of Jak 1 and 3 and thus
negatively influence IL-15-mediated signaling. Transcription of the
Cd122 gene and thus upregulation of CD122 is positively influenced
by the combined action of eomesodermin and T-bet, or by TCR
stimulation (and proliferation). Conversely, Blimp-1 represses T-bet
thereby negatively influencing Cd122 transcription. Contact with
IL-12 or signals from APCs upon CpG binding to TLR9 on APCs (not
shown) leads to inhibition of eomesodermin, whereas these signals
activate T-bet. In contrast, contact with cc cytokines and TCF-1
activity positively influence eomesodermin, which favors the gener-
ation of long-lived memory CD8? T cells, whereas Blimp-1 together
with T-bet favors the generation short-lived effector CD8? T cells.
APC antigen-presenting cell, Blimp-1 B lymphocyte-induced matu-
ration protein 1, Jak Janus kinase, SOCS-1 suppressor of cytokine
signaling 1, STAT5 signal transducer and activator of transcription 5,
TCF-1 T cell factor 1, TCR T cell receptor, TLR Toll-like receptor,
cc common c chain
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cells that upregulate CD25 for a shorter period (thereby
receiving less stimulatory signals) tend to survive as long-
lived memory cells [51, 54]. At the memory stage,
administration of recombinant IL-2 to mice 2 months fol-
lowing LCMV infection has been shown to mediate
proliferation and expansion of virus-specific memory
CD8? T cells and also, to a lesser degree, CD4? T cells
[55, 56]. Vigorous expansion of LCMV-specific memory
CD8? T cells and also naturally occurring MP CD8? T
cells was observed upon adoptive transfer of these cells to
normal mice treated with IL-2/anti-IL-2 mAb complexes
[44, 57]. These observations are in line with studies on
antigen-specific CD8? T cells from mice lacking the co-
inhibitory molecule B and T lymphocyte attenuator
(BTLA, CD272). Thus, BTLA-/- CD8? T cells showed
enhanced primary and secondary antigen responses in vivo,
presumably reflecting that BTLA engagement inhibits IL-2
secretion by T cells [58, 59].
Besides its essential contribution to B cell development
(in mice), IL-7 in concert with tonic TCR signals has a
crucial role in maintaining the survival of naı¨ve CD4? and
CD8? T cells in interphase. IL-7 also contributes to the
survival and intermittent homeostatic proliferation of
memory T cells [56, 60, 61] (Fig. 3). Thus, it is not sur-
prising that virtually all T cells express high levels of
IL-7Ra (CD127). Downregulation of CD127 occurs fol-
lowing TCR engagement in vivo or after contact with IL-2,
IL-4, IL-6, IL-7, or IL-15 in vitro [62–64], although the
role of these cytokines in decreasing CD127 levels in vivo
is controversial [44, 65, 66]. Conversely, several tran-
scription factors including Foxo1 and GA binding protein a
(GABPa) have been implicated in the upregulation of
CD127 in T cells (Fig. 1), as well as PU.1 in pre-B cells
[20, 67, 68]. Moreover, the transcription factor growth
factor independence (Gfi)-1 has been reported to repress
CD127 in CD8? T cells by antagonizing GABPa following
TCR signals in vivo or contact with IL-2, IL-4, IL-6, IL-7,
or IL-15 in vitro [64, 69].
Interestingly, IL-7 signals also influence lymphoid tissue
inducer cells, which are crucial for the development of
secondary lymphoid organs, including LNs and Peyer’s
patches. Lymphoid tissue inducer cells are retinoic acid-
related orphan receptor (ROR)ct? CD4? CD3- cells in the
gut. It has been shown that these cells depend on IL-7
signals, and that increased IL-7 signals lead to the expan-
sion of these cells in vivo [70–72].
Unlike IL-7, responsiveness to IL-15 (and IL-2) is
controlled by expression of CD122, the IL-2/IL-15Rb
subunit. Expression of CD122 is regulated by many factors,
including upregulation following TCR stimulation. In
particular, the T-box transcription factor eomesodermin in
conjunction with T-bet ensures maintenance of high
CD122 levels on long-lived MP CD8? T cells [73, 74].
Eomesodermin is influenced positively by the transcription
factor T cell factor (TCF)-1 as well as by cc cytokine
signals, whereas inflammatory stimuli (such as IL-12 and
CpG) have been found to repress eomesodermin but induce
Fig. 3 Factors involved in the homeostasis of T cells and NK cells.
Lymphocyte subsets are depicted in different colors (blue conven-
tional CD4? and CD8? T cells; red Treg; light orange cd T cell; light
brown NK cell), along with their expression of CD25 (IL-2Ra orange
bar), CD122 (IL-15Rb light green bar), and CD127 (IL-7Ra purple
bar). Expression levels of these cytokine receptors on these lympho-
cyte subsets are indicated by the size of the bars as low (or
background), intermediate, or high. Homeostatic survival and expan-
sion of naı¨ve CD4? and CD8? T cells depends on IL-7 and MHC
molecules, whereas their homeostatic proliferation requires IL-7
signals. Other cytokines able to stimulate naı¨ve T cells, e.g., upon
injection into mice, are IFN-I (i.e., IFN-a/b), IFN-c, and TSLP, as
well as, for naı¨ve CD8? T cells, also IL-2, IL-15, IL-21, and IL-12.
Homeostasis of typical memory CD4? T cells is governed by IL-7
(and IL-15) signals, whereas contact with IL-15 and IL-7 is
responsible for homeostasis of typical memory CD8? T cells, which
can also be boosted by administration of other cc cytokines and IFN-I.
Tregs rely on IL-2 for homeostatic survival and proliferation, while
their homeostatic expansion is dependent on IL-7 and probably also
IL-2. For cd T cells, contact with mainly IL-15 and also IL-7 is
responsible for their maintenance, whereas IL-15 signals are crucial
for NK cell homeostasis. IFN-I type I interferon, MHC major
histocompatibility complex, MHC-I MHC class I, MHC-II MHC class
II, NK natural killer, Treg T regulatory cell, TSLP thymic stromal
lymphopoietin, cc common c chain
T and NK cell homeostasis 1601
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T-bet expression; conversely, T-bet together with B lym-
phocyte-induced maturation protein (Blimp)-1 favors the
generation of short-lived effector CD8? T cells [51, 75–81]
(Fig. 2). CD122 expression is highest on both memory and
MP CD8? T cells, as well as on NK cells and certain other
lymphoid subsets [35, 57, 82]. Accordingly, IL-15 signals
are crucial for the homeostatic proliferation and survival of
each of these subsets (Fig. 3). Contact with IL-15 occurs in
several sites, including the bone marrow, spleen, and LNs,
as well as liver [82–87]. The importance of IL-15 is indi-
cated by the finding that animals deficient in IL-15
production (IL-15-/- mice) or IL-15Ra-mediated trans-
presentation of IL-15 (IL-15Ra-/- mice) show a consid-
erable reduction in numbers of resting MP CD8? T cells,
NK cells, NK T cells, and intraepithelial lymphocytes;
these findings reflect that IL-15 is required largely for
proliferation and expansion of these cells rather than for
their initial formation [83, 88–90]. Conversely, increasing
IL-15 signals in vivo, for example by injecting recombinant
IL-15 or the use of IL-15 transgenic animals, causes con-
siderable expansion of MP CD8? T cells and NK cells
[91–96].
IL-21, which is mainly produced by CD4? T cells, is
able to act on CD8? T cells, either by itself or in synergy
with IL-15 (see below), to enhance CD8? T cell responses
or counts [97–99]. Recently, IL-21 signals delivered to
CD8? T cells during viral infection were found to be
important for the formation of memory CD8? T cells
[100]. Moreover, for memory CD8? T cells forming during
chronic virus infections, IL-21 signals were able to prevent
rapid exhaustion of these cells, thus helping to control the
virus [101–103]. However, injection of IL-21 did not
accelerate homeostatic proliferation of memory CD4? and
CD8? T cells generated following acute virus infections
[56].
Notably, some cc cytokines can act in synergy with other
cc cytokines. Thus, in contrast to IL-15 alone, which has
little effect on naı¨ve CD8? T cells at physiological con-
centrations [35], a combination of exogenous IL-15 and
IL-21 is able to induce proliferation not only of memory
but also naı¨ve CD8? T cells in vitro and lead to increased
CD8? T cell-mediated anti-tumor activity in vivo [98].
Also, IL-15 signals can be supplemented or compensated
for by high concentrations of other cc cytokines, such as by
injecting IL-2, IL-4, or raising IL-7 levels in IL-7 trans-
genic mice. These situations lead to marked increases in
numbers of MP CD8? T cells, even in IL-15-/- mice.
Except in IL-7 transgenic mice, elevating the level of cc
cytokines induces rapid proliferation, as distinct from the
slow intermittent proliferation, characteristic of normal MP
T cell homeostasis [44, 104]. For IL-7, high levels of
thymic stromal lymphopoietin (TSLP), which does not
bind to cc but to CD127 and the TSLP receptor, can
compensate for a lack of IL-7 in T cell homeostasis in vivo
[105, 106].
Increased availability of cc cytokines, especially IL-7
and to a lesser degree IL-15, is found during lymphopenia,
which occurs naturally in the neonatal period of mice or
upon removal of T and B cells from adults, for example
following whole body irradiation [15, 107]. Lymphopenia
reduces consumption of IL-7 (and IL-15), thereby
increasing its availability to residual T cells and after
adoptive T cell transfer to lymphopenic hosts [15, 108]. As
a result, both conventional T cells and Tregs are subjected
to increased IL-7 (and IL-15) signaling, thereby causing the
cells to undergo acute ‘‘homeostatic’’ proliferation, also
termed homeostatic expansion or lymphopenia-induced
proliferation [109–112]. For naı¨ve T cells, homeostatic
expansion is dependent not only on IL-7 but also on TCR
contact with self-peptide/MHC complexes. Following
homeostatic expansion, naı¨ve T cells acquire the pheno-
typic and functional properties of memory T cells. As
mentioned earlier, most MP T cells may be self-reactive
and represent the progeny of naı¨ve T cells responding to
self-antigens during episodes of homeostatic expansion
[7, 109–111, 113, 114]. Interestingly, lack of suppressor of
cytokine signaling (SOCS)-1 renders naı¨ve CD8? T cells
hyperresponsive to IL-15 signals, thus causing self-peptide/
MHC molecule-dependent ‘‘homeostatic expansion’’ even
under non-lymphopenic conditions [115, 116]. Moreover,
under conditions where in vivo levels of either IL-2 or
IL-15 are elevated, naı¨ve T cells undergo a form of
homeostatic expansion that is MHC-dependent, but much
more rapid than the typical pattern of slow homeostatic
expansion driven by IL-7 [117]. In addition to cytokines
and self-peptide/MHC molecules, homeostatic expansion
of T cells can be influenced by other factors such as
expression of lymphocyte activation gene-3 (LAG-3,
CD223), BTLA (CD272), the transmembrane adaptor pro-
tein SIT, and heat-stable antigen (CD24). Thus,
homeostatic expansion of LAG-3-, BTLA-, or SIT-deficient
naı¨ve CD8? T cells is faster and more intense than for
normal cells [59, 118, 119]. Conversely, CD24-deficient T
cells show a considerable reduction in their tempo of pro-
liferation during homeostatic expansion [120]. For
homeostatic expansion of memory T cells, it should be
mentioned that these cells are heavily dependent on contact
with both IL-7 and IL-15, but do not require interaction
with peptide/MHC molecules [15].
Other cytokines
As mentioned above, IFNs, particularly IFN-a/b (IFN-I),
can lead to IL-15 production by APCs and thereby induce
proliferation of memory and MP CD8? T cells. In addition,
IFN-I is also able to act directly on naı¨ve antigen-specific
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123
CD8? and CD4? T cells and promote expansion and sur-
vival of these cells during an immune response, such as
following infection with LCMV [121, 122]. This direct
action of IFN-I provides a so-called ‘‘third signal’’ to the
responding T cells and can also be delivered by IL-12
[123]. In certain situations, however, IFN-I might exert a
negative role on CD8? T cells following viral infection,
particularly on memory CD8? T cells [124]. With regard to
other cytokines, IFN-c has been found to resemble IFN-I in
being able to act directly on naı¨ve CD8? and CD4? T cells
by improving antigen-mediated expansion of these cells
[125, 126] (Fig. 3).
Certain cytokines, notably TGF-b and IL-10, are pro-
duced by some Tregs and can have a marked inhibitory
action on T cells, although data from recent years have
shown that the contribution of these cytokines to the
quality of the immune response is highly variable, espe-
cially for CD8? T cells [127]. Thus, in certain situations,
IL-10 can boost expansion and memory formation of
antigen-specific CD8? T cells, for example during acute
bacterial infection [128, 129]. However, during prolonged
immune responses, IL-10 seems to be suppressive. Thus, in
chronic LCMV infection, it was found that blocking IL-10
production, either by genetic removal or injection of anti-
body, reversed the anergic phenotype of antigen-specific
CD8? and CD4? effector T cells, thereby leading to virus
clearance and the generation of functional antigen-specific
memory T cells [130, 131].
For TGF-b, this cytokine has a role in regulating the
survival and differentiation of Tregs and effector CD4? T
cells [39, 132]. Conversely, for CD8? T cells, TGF-b
signals might influence responsiveness of CD8? T cells to
homeostatic cues, such as TCR and cytokine signals [132].
Thus, T cell-targeted deletion of the TGF-b receptor II led
to the emergence of activated, effector-like CD62Llow
CD44high CD8? T cells undergoing rapid homeostatic
proliferation [132]. Based on these characteristics, TGF-b
receptor-deficient CD8? T cells display features of
memory T cells that continue to interact with their cognate
(self-)antigen. Interestingly, a recent study showed that
attenuation of TGF-b signaling in T cells resulted in a
reversal of the anergic phenotype of antigen-specific
memory CD8? T cells generated during a chronic viral
infection, thus leading to eradication of the virus [133].
cd T cells
T cells expressing cd TCRs are non-conventional T cells
that recognize non-peptide antigens, which are upregulated
upon tissue stress [134, 135]. Recognition of these stress-
induced molecules by cd T cells is achieved via binding of
their (semi-)invariant cd TCRs in addition to triggering of
other stimulatory molecules, such as TLRs. In addition to
being present in secondary lymphoid organs and the liver,
cd T cells reside in epithelial surfaces, such as the skin and
the mucosa of the respiratory, digestive, and reproductive
systems [134, 135]. Homeostasis of cd T cells has been
reported to require contact with cytokines, but not with
MHC molecules. Thus, cc cytokines, notably IL-7 and IL-15,
have been implicated in mediating these processes, as mice
deficient in these cytokines or their receptors lack (subsets)
of cd T cells [89, 136–139]. Accordingly, cd T cells
express high levels of CD127 and CD122 [140]. Similar
to ab TCR? T cells and NK cells, injection of cd T cells
to lymphopenic hosts also lacking cd T cells leads to
homeostatic expansion of transferred cd T cells, which is
driven by IL-15 and IL-7 [140, 141]. Thus, cd T cells
compete for the same cytokine signals as T cells, notably
CD8? ab TCR? T cells, and NK cells during homeostatic
expansion, while contact with MHC molecules does not
seem to be required for such expansion [141]. Interestingly,
an NK1.1? subset of cd T cells shows a slower rate of
homeostatic expansion, compared to CD8? cd T cells [142]
Natural killer cells
IL-2 is known as a potent NK cell stimulatory factor, both
in vitro and in vivo, and NK cells expand considerably
following treatment with CD122-specific IL-2/anti-IL-2
mAb complexes, similar to MP CD8? T cells [44, 57, 143].
However, IL-2 probably plays only a minor role in the
steady-state homeostasis of NK cells, in contrast to IL-15,
which is crucial for survival and homeostatic proliferation
of NK cells under normal conditions [144] (Fig. 3). As
mentioned above, IL-15-/- and IL-15Ra-/- mice both
lack NK cells, whereas increased IL-15 signals in vivo lead
to expansion of NK cells [89–95]. Conversely, the
peripheral pool size of NK cells in IL-2-/- IL-4-/- IL-
7-/- triple-deficient mice on a recombinase-activating
gene (RAG)-/- background is normal and functional, thus
showing that these cc cytokines are dispensable for NK cell
generation and survival [145]. Interestingly, IL-15-medi-
ated expansion of NK cells is antagonized by IL-21 in
vitro, whereas NK cells receiving IL-21 signals show
enhanced cytotoxicity and IFN-c production upon stimu-
lation with poly(I:C) in vivo or IL-15 in vitro [146].
Similar to T cells, NK cells undergo expansion upon
transfer to lymphopenic mice and, like MP T cells, acquire
characteristics of long-lived memory cells [147]. However,
such ‘‘homeostatic expansion’’ requires adoptive transfer of
NK cells to NK cell-deficient mice, notably RAG-/- cc
-/-
double knockout mice. Such RAG-/- cc
-/- mice probably
contain increased cytokine levels of both IL-7 and IL-15,
reflecting a lack of consumption of these cytokines [144,
148]. Moreover, in very young mice, i.e., at the age of
1 month or less, turnover of NK cells is considerably
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increased, suggesting that NK cells, like MP CD8? T cells,
undergo homeostatic expansion [149]. Such expansion of
NK cells probably depends largely on contact with IL-15,
with little or no role for IL-7 or other cc cytokines [145].
Interestingly, KLRG? NK cells show poor IL-15 responses
in terms of homeostatic proliferation and homeostatic
expansion [148]. Also, MHC class I molecules do not seem
to be involved in homeostatic NK cell expansion [149].
IL-12 and IL-18 are able to activate NK cells when
added in vitro. However, neither of these cytokines nor
IFNs have been implicated in the normal homeostasis of
NK cells in vivo. Likewise, there is no evidence that NK
cell homeostasis involves TGF-b or IL-10.
Concluding remarks and summary
Collectively, homeostasis of lymphocytes is governed by
cytokines, most notably cc cytokines, and, for some lym-
phocytes, also signals received from antigen-receptors
(Fig. 3). Thus, homeostatic survival and homeostatic
expansion of naı¨ve CD4? and CD8? T cells depends on
IL-7 and self-peptide/MHC molecules, whereas homeo-
static proliferation of these cells requires IL-7 (and IL-15)
signals. Other cytokines able to stimulate naı¨ve CD4?
T cells are IFNs and TSLP, whereas naı¨ve CD8? T cells
can also be stimulated with increased levels of IL-2, IL-15,
IL-21, and IL-12.
Homeostasis of typical (central) memory and MP CD4?
T cells is governed by IL-7 (and IL-15) signals, whereas
contact with IL-15 and IL-7 is responsible for homeostasis
of typical (central) memory and MP CD8? T cells. Ele-
vated levels of other cc cytokines, e.g., following injection
of recombinant cytokine or IFN-I, are able to boost num-
bers of memory CD8? T cells, while enhanced IL-2 signals
can lead to an increase in memory CD4? T cell counts.
Notably, both MP cells and memory CD8? T cells gener-
ated by homeostatic proliferation closely resemble antigen-
specific memory CD8? T cells formed during responses to
pathogens; thus, all these CD8? T subsets are long-lived
and dependent on IL-7 and IL-15 [15, 25, 56]. Also, MP
CD4? T cells are similar to pathogen-specific memory
CD4? T cells in being dependent on IL-7 (and IL-15)
signals [15, 25, 56, 150] (Fig. 3). However, unlike memory
CD8? T cells, the frequency of pathogen-specific memory
CD4? T cells tends to decrease with time [13, 151, 152].
The precise cause of this decline remains unclear.
In contrast to the above-mentioned T cell subsets, CD4?
Tregs rely on IL-2 signals for their homeostatic survival
and proliferation. Homeostatic expansion of CD4? Tregs in
lymphopenic hosts is driven by elevated IL-7 levels and
probably also depends on paracrine IL-2 signals from
activated T cells. Interestingly, it has been suggested that
strong IL-15 signals might also impact on Tregs and lead to
their expansion [153].
Similar to memory CD8? T cells, homeostasis of cd T
cells relies on contact with mainly IL-15 and also IL-7. For
NK cells, IL-15 signals are crucial for their homeostatic
maintenance under steady-state conditions. Furthermore,
increased IL-2 levels are well known to potently activate
and expand NK cells.
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